530030 Sigma-AldrichGlutaminase Inhibitor II, BPTES - CAS 314045-39-1 - Calbiochem
A cell-permeable, potent, selective, reversible, and uncompetitive allosteric inhibitor of kidney-type glutaminase (GLS1). Does not affect the activity of liver glutaminase.
More>> A cell-permeable, potent, selective, reversible, and uncompetitive allosteric inhibitor of kidney-type glutaminase (GLS1). Does not affect the activity of liver glutaminase. Less<<Synonyms: N,Nʹ-(5,5ʹ-(2,2ʹ-Thiobis(ethane-2,1-diyl))bis(1,3,4-thiadiazole-5,2-diyl))bis(2-phenylacetamide), Kidney-Type Glutaminase Inhibitor II, GAC Inhibitor II, GLS1 Inhibitor II, KGA Inhibitor II
Recommended Products
Overview
Replacement Information |
---|
Key Specifications Table
CAS # | Empirical Formula |
---|---|
314045-39-1 | C₂₄H₂₄N₆O₂S₃ |
Pricing & Availability
Catalog Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
---|---|---|---|---|---|---|
5.30030.0001 |
|
Glass bottle | 10 mg |
|
— |
Product Information | |
---|---|
CAS number | 314045-39-1 |
Form | Yellow powder |
Hill Formula | C₂₄H₂₄N₆O₂S₃ |
Chemical formula | C₂₄H₂₄N₆O₂S₃ |
Reversible | Y |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | kidney-type glutaminase |
Primary Target IC<sub>50</sub> | 140 and 210 nM in HEK293 cells expressing wt-KGA and F318Y-cKGA, respectively |
Purity | ≥94% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalog Number | GTIN |
5.30030.0001 | 04055977241198 |
Documentation
Glutaminase Inhibitor II, BPTES - CAS 314045-39-1 - Calbiochem SDS
Title |
---|
References
Reference overview |
---|
Shukla, K., et al. 2012. J. Med. Chem. 55, 10551. Thangavelu, K., et al. 2012. Proc. Natl. Acad. Sci. USA 109, 7705. Le, A., et al. 2012. Cell Metab. 15, 110. DeLaBarre, B., et al. 2011. Biochemistry 50, 10764. Seltzer, M.J., et al. 2010. Cancer Res. 70, 8981. Robinson, M.M., et al. 2007. Biochem. J. 406, 407. |